Cell No. : Cell Name
RCB2816 : A110L
update : 2024/04/04
|
| Comment | Human cell line derived from lung adenocarcinoma cells. |
| Comment from the depositor | |
| Terms and conditions | In publishing research results obtained by the use of the BIOLOGICAL RESOURCE, a citation of the literature ref. (Jpn J Cancer Res 1998;89:60-66) designated by the DEPOSITOR is required. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Yasumoto, Kosei
|
| Originator |
Yasumoto, Kosei
|
| Year of deposit |
2008
|
| Animal |
_human
< Mammals
|
| Genus |
Homo
|
| Species |
sapiens
|
| Race |
Japanese
|
| Gender |
Male
|
| Age at sampling |
61 years
|
| Tissue |
lung
|
| Disease name |
adenocarcinoma
|
| Classification |
cancer
|
| Year of origin |
1996
|
|
Lifespan |
infinite
|
| Morphology |
epithelial-like
|
| Cellosaurus(Expasy) |
CVCL_U093
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Adherent cells
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| Isozyme |
|
LD, NP
|
| STR(human) |
|
OK
|
|
deposit info
|
|
|
lot info
|
| D5S818 |
D13S317 |
D7S820 |
D16S539 |
vWA |
TH01 |
Amelogenin |
TPOX |
CSF1PO |
|
11.13
|
8,11
|
11
|
11
|
14
|
6,9
|
X,Y
|
8,11
|
9,11
|
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
9
|
| User's Publication |
1
|
| Reference |
|
8991
Manabu Yasuda, Takeshi Hanagiri, Yoshiki Shigematsu, Takamitsu Onitsuka, Kouji Kuroda, Tetsurou Baba, Makiko Mizukami, Yoshinobu Ichiki, Hidetaka Uramoto, Mitsuhiro Takenoyama, Kosei Yasumoto
Identification of a Tumour Associated Antigen in Lung Cancer Patients With Asbestos Exposure
Anticancer Res
2010
30 (7), 2631-9
PubMed ID: 20682992
|
|
3628
Baba T, Hanagiri T, Ichiki Y, Kuroda K, Shigematsu Y, Mizukami M, Sugaya M, Takenoyama M, Sugio K, Yasumoto K.
Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Cancer Sci
2007
98(11):1795-802
PubMed ID: 17725806
DOI: 10.1111/j.1349-7006.2007.00586.x
|
|
3637
Sugaya M, Takenoyama M, Shigematsu Y, Baba T, Fukuyama T, Nagata Y, Mizukami M, So T, Ichiki Y, Yasuda M, So T, Hanagiri T, Sugio K, Yasumoto K.
Identification of HLA-A24 restricted shared antigen recognized by autologous cytotoxic T lymphocytes from a patient with large cell carcinoma of the lung.
Int J Cancer
2007
120(5):1055-62
PubMed ID: 17131342
DOI: 10.1002/ijc.22396
|
|
8995
Takashi Fukuyama, Yoshinobu Ichiki, Sousuke Yamada, Yoshiki Shigematsu, Tetsuro Baba, Yoshika Nagata, Makiko Mizukami, Masakazu Sugaya, Mitsuhiro Takenoyama, Takeshi Hanagiri, Kenji Sugio, Kosei Yasumoto
Cytokine Production of Lung Cancer Cell Lines: Correlation Between Their Production and the Inflammatory/Immunological Responses Both in Vivo and in Vitro
Cancer Sci
2007
98 (7), 1048-54
PubMed ID: 17511773
DOI: 10.1111/j.1349-7006.2007.00507.x
|
|
9004
Makiko Mizukami, Takeshi Hanagiri, Manabu Yasuda, Koji Kuroda, Yoshiki Shigematsu, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Tetsuya So, Yoshinobu Ichiki, Masakazu Sugaya, Tomoko So, Mitsuhiro Takenoyama, Kenji Sugio, Kosei Yasumoto
Antitumor Effect of Antibody Against a SEREX-defined Antigen (UOEH-LC-1) on Lung Cancer Xenotransplanted Into Severe Combined Immunodeficiency Mice
Cancer Res
2007
67 (17), 8351-7
PubMed ID: 17804751
DOI: 10.1158/0008-5472.CAN-06-3889
|
|
8988
Takashi Fukuyama, Takeshi Hanagiri, Mitsuhiro Takenoyama, Yoshinobu Ichiki, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Tomoko So, Kenji Sugio, Kosei Yasumoto
Identification of a New Cancer/Germline Gene, KK-LC-1, Encoding an Antigen Recognized by Autologous CTL Induced on Human Lung Adenocarcinoma
Cancer Res
2006
66 (9), 4922-8
PubMed ID: 16651449
DOI: 10.1158/0008-5472.CAN-05-3840
|
|
7413
Mizukami M, Hanagiri T, Baba T, Fukuyama T, Nagata Y, So T, Ichiki Y, Sugaya M, Yasuda M, Takenoyama M, Sugio K, Yasumoto K.
Identification of tumor associated antigens recognized by IgG from tumor-infiltrating B cells of lung cancer: correlation between Ab titer of the patient's sera and the clinical course.
Cancer Sci
2005
96(12):882-8
PubMed ID: 16367908
DOI: 10.1111/j.1349-7006.2005.00119.x
|
|
8998
Yoshinobu Ichiki, Takeshi Hanagiri, Mitsuhiro Takenoyama, Tetsuro Baba, Takashi Fukuyama, Yoshika Nagata, Makiko Mizukami, Tetsuya So, Masakazu Sugaya, Manabu Yasuda, Tomoko So, Kenji Sugio, Kosei Yasumoto
Tumor Specific Expression of survivin-2B in Lung Cancer as a Novel Target of Immunotherapy
Lung Cancer
2005
48 (2), 281-9
PubMed ID: 15829330
DOI: 10.1016/j.lungcan.2004.10.017
|
|
3625
Takenoyama 1, Yoshino I, Fujie H, Hanagiri T, Yoshimatsu T, Imabayashi S, Eifuku R, Nomoto K, Yasumoto K.
Autologous tumor-specific cytotoxic T lymphocytes in a patient with lung adenocarcinoma: implications of the shared antigens expressed in HLA-A24 lung cancer cells.
Jpn J Cancer Res.
1998
89(1):60-6.
PubMed ID: 9510477
DOI: 10.1111/j.1349-7006.1998.tb00480.x
|
Back
Top
CELL BANK Website
